pubmed-article:8206321 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C0038317 | lld:lifeskim |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C0521428 | lld:lifeskim |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C0521457 | lld:lifeskim |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C0040690 | lld:lifeskim |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:8206321 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:8206321 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:8206321 | pubmed:dateCreated | 1994-7-11 | lld:pubmed |
pubmed-article:8206321 | pubmed:abstractText | Transforming growth factor-beta (TGF-beta) was found to inhibit basal and ACTH-stimulated steroid production by cultured human fetal adrenal cells. The inhibitory effects of TGF-beta were both time and dose-dependent. Inhibition of basal dehydroepiandrosterone sulfate (DS) production usually was noted only after 3 or more days of treatment with > or = 0.1 ng TGF-beta/ml. The inhibitory effects of 1 ng/ml TGF-beta on ACTH-stimulated DS production were more striking than those on cortisol production by both fetal zone and neocortical cells. TGF-beta also was found to interfere with DS and cortisol production by fetal zone cells in response to forskolin and dibutyryl cAMP. TGF-beta interfered with ACTH stimulation of cytochrome P450(17) alpha mRNA in fetal zone and neocortex cells. These results are suggestive that TGF-beta differentially inhibits DS and cortisol production by human fetal adrenal cells and that the site of TGF-beta action on steroidogenesis may be distal to the generation of cAMP. Such results, along with those of others, are suggestive that TGF-beta may play an autocrine/paracrine role in the human adrenal. | lld:pubmed |
pubmed-article:8206321 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:language | eng | lld:pubmed |
pubmed-article:8206321 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8206321 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8206321 | pubmed:month | Mar | lld:pubmed |
pubmed-article:8206321 | pubmed:issn | 0303-7207 | lld:pubmed |
pubmed-article:8206321 | pubmed:author | pubmed-author:ParkerC RCRJr | lld:pubmed |
pubmed-article:8206321 | pubmed:author | pubmed-author:DionL DLD | lld:pubmed |
pubmed-article:8206321 | pubmed:author | pubmed-author:StankovicA... | lld:pubmed |
pubmed-article:8206321 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8206321 | pubmed:volume | 99 | lld:pubmed |
pubmed-article:8206321 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8206321 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8206321 | pubmed:pagination | 145-51 | lld:pubmed |
pubmed-article:8206321 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:meshHeading | pubmed-meshheading:8206321-... | lld:pubmed |
pubmed-article:8206321 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8206321 | pubmed:articleTitle | Effects of transforming growth factor-beta on human fetal adrenal steroid production. | lld:pubmed |
pubmed-article:8206321 | pubmed:affiliation | Department of Obstetrics and Gynecology, University of Alabama at Birmingham 35233-7333. | lld:pubmed |
pubmed-article:8206321 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8206321 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8206321 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8206321 | lld:pubmed |